Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.06%
- Poor long term growth as Net Sales has grown by an annual rate of 2.35% and Operating profit at -195.74% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Mar 25
3
With ROE of 35.16%, it has a very attractive valuation with a 1.13 Price to Book Value
Stock DNA
Other Agricultural Products
CNY 3,598 Million (Large Cap)
3.00
NA
0.00%
0.52
35.16%
1.13
Revenue and Profits:
Net Sales:
2,168 Million
(Quarterly Results - Jun 2025)
Net Profit:
154 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.67%
0%
41.67%
6 Months
19.22%
0%
19.22%
1 Year
15.91%
0%
15.91%
2 Years
-50.54%
0%
-50.54%
3 Years
-71.72%
0%
-71.72%
4 Years
-55.13%
0%
-55.13%
5 Years
-70.05%
0%
-70.05%
Fujian Aonong Biological Technology Group, Inc. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.35%
EBIT Growth (5y)
-195.74%
EBIT to Interest (avg)
-1.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
2.24
Tax Ratio
4.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.06%
ROE (avg)
11.72%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
1.13
EV to EBIT
-9.94
EV to EBITDA
33.49
EV to Capital Employed
1.09
EV to Sales
0.65
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
-10.93%
ROE (Latest)
35.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,168.30
1,775.80
22.10%
Operating Profit (PBDIT) excl Other Income
149.80
126.10
18.79%
Interest
30.60
36.50
-16.16%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
153.70
221.70
-30.67%
Operating Profit Margin (Excl OI)
11.60%
0.80%
1.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 22.10% vs -2.79% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -30.67% vs -78.19% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
8,733.00
19,419.70
-55.03%
Operating Profit (PBDIT) excl Other Income
-0.50
-1,344.70
99.96%
Interest
655.60
574.10
14.20%
Exceptional Items
2,396.90
-457.30
624.14%
Consolidate Net Profit
63.10
-3,768.70
101.67%
Operating Profit Margin (Excl OI)
-106.10%
-137.30%
3.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -55.03% vs -9.98% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 101.67% vs -207.45% in Dec 2023
About Fujian Aonong Biological Technology Group, Inc. Ltd. 
Fujian Aonong Biological Technology Group, Inc. Ltd.
Other Agricultural Products
No Details Available.
Company Coordinates 
No Company Details Available






